- Molmed S.p.a Company News Section

Molmed S.p.a Information
  • Monica Salomoni
  • Phone: 393902212771
  • URL:
  • MolMed S.p.A. is a biotechnology company focused on research, development and clinical validation of novel anti-tumour therapies. MolMed%u2019s pipeline includes two novel therapeutics both in Phase III trials. MolMed%u2019s shares are listed on the Milan Stock Exchange, at the Standard segment (class I) of the MTA managed by Italiana. (Ticker Reuters: MLMD.MI).
Molmed S.p.a Press Release -